An Update on Emerging Regenerative Medicine Applications: The Use of Extracellular Vesicles and Exosomes for the Management of Chronic Pain
William D. Shipman,Raquel Fonseca,Moises Dominguez,Sadiq Bhayani,Christopher Gilligan,Sudhir Diwan,David Rosenblum,Sait Ashina,Reda Tolba,Alaa Abd-Elsayed,Alan D. Kaye,Jamal Hasoon,Michael E. Schatman,Timothy Deer,Jason Yong,Christopher L. Robinson
DOI: https://doi.org/10.1007/s11916-024-01309-4
2024-11-04
Current Pain and Headache Reports
Abstract:Chronic pain affects nearly two billion people worldwide, surpassing heart disease, diabetes, and cancer in terms of economic costs. Lower back pain alone is the leading cause of years lived with disability worldwide. Despite limited treatment options, regenerative medicine, particularly extracellular vesicles (EVs) and exosomes, holds early promise for patients who have exhausted other treatment options. EVs, including exosomes, are nano-sized structures released by cells, facilitating cellular communication through bioactive molecule transfer, and offering potential regenerative properties to damaged tissues. Here, we review the potential of EVs and exosomes for the management of chronic pain.
clinical neurology